Kolexia
Fanciullino Raphaelle
Pharmacien
Hôpital La Conception
Marseille, France
100 Activités
22 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Leucémie aigüe myéloïde Leucémies Leucémie myéloïde Lymphomes Tumeurs hématologiques Syndromes myélodysplasiques Myélome multiple Tumeurs expérimentales de la mamelle

Industries

Janssen
13 collaboration(s)
Dernière en 2022
Incyte
4 collaboration(s)
Dernière en 2021
Novartis
4 collaboration(s)
Dernière en 2023
Fresenius Kabi
3 collaboration(s)
Dernière en 2021

Dernières activités

Poor Prognosis of SRSF2 Gene Mutations in Patients Treated with Venetoclax-Azacitidine (VEN-AZA) for Newly Diagnosed Acute Myeloid Leukemia. a Multicentric Real-Life Study of 117 Patients
65th ASH Annual Meeting Abstracts   02 novembre 2023
Cytidine deaminase status as a marker of response to azacytidine treatment in MDS and AML patients.
British journal of haematology   10 septembre 2023
Harnessing tumor immunity with cytotoxics: T cells monitoring in mice bearing lung tumors treated with anti-VEGF and pemetrexed-cisplatin doublet.
British journal of cancer   31 juillet 2023
Abstract 1856: Pemetrexed-cisplatin-bevacizumab combo in lung cancer models: impact on tumor immunity
Proceedings: AACR Annual Meeting 2023   01 avril 2023
Abstract 1857: Nanoliposomes harness tumor immunity in breast cancer models
Proceedings: AACR Annual Meeting 2023   01 avril 2023
Determination of 5-azacitidine in human plasma by LC-MS/MS: application to pharmacokinetics pilot study in MDS/AML patients.
Cancer chemotherapy and pharmacology   01 mars 2023
Tumor growth monitoring in breast cancer xenografts: A good technique for a strong ethic.
PloS one   30 septembre 2022
Successful treatment with adapted high dose methotrexate in a hemodialysis patient with primary central nervous system lymphoma: 100mg/m seems sufficient.
Nefrologia   28 septembre 2022
Macro-scale models for fluid flow in tumour tissues: impact of microstructure properties.
Journal of mathematical biology   28 février 2022
Pharmacokinetics and pharmacogenetics of liposomal cytarabine in AML patients treated with CPX-351.
Journal of controlled release : official journal of the Controlled Release Society   18 août 2021